GPC sobre el TDAH (res.) - GuíaSalud

208 Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, FeldmanPD, et al. Effects of long-term atomoxetine treatment for young childrenwith attention-deficit/hyperactivity disorder. J Am Acad ChildAdolesc Psychiatry. 2006 Aug;45(8):919-27.209 Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, RogersAK, et al. Long-term atomoxetine treatment in adolescents withattention-deficit/hyperactivity disorder. J Pediatr. 2006 Jul;149(1):112-9.210 Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, FeldmanHM, et al. Treatment of attention-deficit/hyperactivity disorder: overviewof the evidence. Pediatrics. 2005 Jun;115(6):e749-e757.211 FDA Alert [09/05]: Suicidal thinking in children and adolescents. U SFood and Drug Administration 2005 December 29. Disponible en: URL:http://www.fda.gov/cder/drug/infopage/atomoxetine/default.htm.212 Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, et al. Cardiovascularmonitoring of children and adolescents with heart diseasereceiving stimulant drugs: a scientific statement from the AmericanHeart Association Council on Cardiovascular Disease in the YoungCongenital Cardiac Defects Committee and the Council on CardiovascularNursing. Circulation. 2008 May 6;117(18):2407-23.213 Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, et al. Cardiovasculareffects of atomoxetine in children, adolescents, and adults.Drug Saf. 2003;26(10):729-40.214 Perrin JM, Friedman RA, Knilans TK. Cardiovascular monitoring andstimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics.2008 Aug;122(2):451-3.215 Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL,Feldman PD, et al. Transition from methylphenidate or amphetamineto atomoxetine in children and adolescents with attention-deficit/hyperactivitydisorder—a preliminary tolerability and efficacy study. ClinTher. 2007 Jun;29(6):1168-77.216 Weiss MD, Virani A, Wasdell M, Faulkner L, Rea K. Atomoxetine inclinical practice. Future Neurology. 2006;1:249-58.217 Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, JacobsenSJ. Long-term stimulant medication treatment of attentiondeficit/hyperactivitydisorder: results from a population-based study. JDev Behav Pediatr. 2006 Feb;27(1):1-10.218 Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, PearlPL, et al. A dose-response study of OROS methylphenidate in childrenwith attention-defi cit/hyperactivity disorder. Pediatrics. 2003Nov;112(5):e404.219 Smith BH, Pelham WE, Evans S, Gnagy E, Molina B, Bukstein O, et188 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS